Company Filing History:
Years Active: 2023
Title: Eun Jeong Sohn: Innovator in Protein Transduction Domains
Introduction
Eun Jeong Sohn is a notable inventor based in Namyangiu-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of protein transduction domains. His innovative work has the potential to enhance the delivery of therapeutic agents into living cells.
Latest Patents
Eun Jeong Sohn holds a patent for a "Protein transduction domain, fusion compound containing the same, and pharmaceutical composition containing the fusion compound." This invention proposes a more efficient protein transduction domain and fusion compound. The research led to the discovery of a GK1 peptide comprising 18 amino acids, which can bond with high-molecular-weight materials such as proteins. This bonding allows these materials to penetrate living bodies, including cells, tissues, or blood, effectively. The fusion compound, oligonucleotide, or vector derived from this invention can be utilized as a pharmaceutical composition for preventing or treating diseases.
Career Highlights
Eun Jeong Sohn is associated with Genesen Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic delivery systems, which can have a profound impact on medical treatments.
Collaborations
Eun Jeong Sohn collaborates with talented individuals in his field, including Soo-Young Choi and Jin-Seu Park. Their combined expertise contributes to the innovative projects at Genesen Co., Ltd.
Conclusion
Eun Jeong Sohn's contributions to the field of biotechnology, particularly through his patent on protein transduction domains, highlight his role as a leading inventor. His work promises to enhance the efficacy of pharmaceutical compositions, paving the way for advancements in medical treatments.